MXC Capital Limited Subscribes to additional Loan Notes in IDE Group Holdings plc

MXC Capital Limited ORD NPV
[shareaholic app="share_buttons" id_name="post_below_content"]

MXC Capital Limited (LON: MXCP), the technology focused adviser and investor, announced today that, further to the announcement of 10 January 2019, pursuant to the terms of the an underwriting agreement it entered into with IDE Group Holdings plc, MXC will subscribe for an additional £3.7 million of secured loan notes in IDE. The terms of the IDE Loan Notes were detailed in the announcement of 10 January 2019. MXC will receive an underwriting fee of £0.21 million from IDE. Following the Further Subscription, MXC will hold £8 million of the £10 million IDE Loan Notes and 43.1 per cent. of the issued share capital of IDE.

IDE is a mid-market network, cloud and IT managed services provider. Ian Smith, CEO of MXC, is an Executive Director of IDE and MXC Capital Markets LLP acts as financial adviser to IDE. Further details about IDE (including latest announcements and financial reports) are available at www.idegroup.com.

MXC Capital Limited is a specialist technology adviser and investor with a track record of investing in and advising companies in the TMT sector. MXC brings together a deep knowledge of technology, first-hand experience of managing companies in the sector, an ability to make meaningful investments and a highly experienced corporate advisory team in support, all of which combine to grow shareholder value.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Argent BioPharma Ltd, formerly MGC Pharmaceuticals Limited, is a pioneering drug discovery company in the biopharmaceutical sector. Learn about their recent name change and impactful advancements in drug development.

      Search

      Search